EFX insider notice: 3,000 vested shares to be sold on NYSE

Rhea-AI Filing Summary

Equifax (EFX) Form 144 notice reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services with an aggregate market value of $742,050. The shares represent restricted stock that vested and were acquired on 02/23/2024 as compensation from the issuer. The filing shows 123,797,380 shares outstanding and lists an approximate sale date of 08/18/2025 on the NYSE. The filer states there were no securities sold in the past three months and makes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Transaction originates from restricted stock vesting, indicating compensation rather than a forced sale
• Small relative size: 3,000 shares equal approximately 0.0024% of outstanding shares, so immaterial to capitalization
• No sales in prior three months, limiting near-term insider selling activity disclosed

Negative

• None materially significant disclosed in this filing that would affect investor valuation

Insights

Securities Analyst

TL;DR Small insider sale notice: 3,000 vested shares for compensation, modest relative size, routine disclosure under Rule 144.

The Form 144 documents a proposed sale of 3,000 common shares valued at $742,050 to be executed via Fidelity on NYSE around 08/18/2025. These shares were acquired through restricted stock vesting on 02/23/2024 and paid as compensation. Relative to the reported 123,797,380 shares outstanding, the proposed sale represents approximately 0.0024% of the outstanding common stock, indicating the transaction is immaterial to overall capitalization. The filer also reports no other sales in the prior three months and affirms no undisclosed material adverse information.

Corporate Governance Expert

TL;DR Governance-wise this is a routine disclosure tied to compensation vesting and does not signal governance or control changes.

The notice shows the securities originated from restricted stock vesting granted by the issuer, suggesting standard executive or employee compensation mechanics rather than a deliberate divestiture for corporate control reasons. The absence of other sales in the preceding three months and the small size relative to total shares outstanding reduce the likelihood of significant governance implications. The required attestation regarding material information is included.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	742050.00	123797380	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2024	Restricted Stock Vesting	Issuer			3000	02/23/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Equifax's (EFX) Form 144 report?

The filing reports a proposed sale of 3,000 common shares acquired via restricted stock vesting on 02/23/2024, with an aggregate market value of $742,050.

When is the approximate sale date listed on the Form 144 for EFX?

The approximate date of sale is listed as 08/18/2025 and the sale is to be effected on the NYSE through Fidelity Brokerage Services.

How material is the proposed sale relative to Equifax's outstanding shares?

The filing reports 123,797,380 shares outstanding; 3,000 shares represent about 0.0024% of that total, which is immaterial to capitalization.

Were there any other securities sold by the filer in the past three months?

The Form 144 states Nothing to Report for securities sold during the past three months.

How were the shares acquired according to the filing?

The shares were acquired on 02/23/2024 through Restricted Stock Vesting from the issuer and the payment nature is listed as Compensation.